Kiran Mazumdar-Shaw is an Indian billionaire entrepreneur. She is the chairperson and managing director of Biocon Limited, a biotechnology company based in Bangalore, India and the chairperson of Indian Institute of Management, Bangalore.
As the 21-day nationwide lockdown kicked in on Wednesday, business tycoons came out in support of the government decision and also offered on social media suggestions, ranging from helping the under-privileged to enforcement of lockdown through awareness and empathy.
Leading biotechnology company Biocon on Thursday reported a net profit of Rs 203 crore for the third quarter (October-December) of fiscal 2019-20, declining by 7 per cent compared to Rs 217 crore in the same quarter last year.
Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business.
Pharmaceuticals major Biocon Ltd on Monday said that its subsidiary Biocon Biologics India has approved the acquisition of 2.44 per cent stake in it by private equity firm True North with an investment of Rs 536.25 crore.
Bhartiya Janata Party (BJP) Spokesperson Amit Malviya and industrialist, Kiran Mazumdar Shaw were on Monday locked in a fiery argument whether she funds the Independent Public Spirited Media Foundation (IPSMF), which in turn supports anti-Modi propaganda.
Embodying beauty, determination and strength, the October issue of Femina magazine brought together the 'power of three' -- actor Deepika Padukone, world champ PV Sindhu and boss lady Kiran Mazumdar Shaw for their anniversary special cover!
Biocon Biologics reduced the retail price of its recombinant human insulin 50 per cent in the low-and-middle income countries, the biotech major said on Friday.